glp-1 articles receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read The GLP-1 Era: Why These

As researchers concluded, Our results strongly support the addition of anti-obesity medications for patients who do not achieve meaningful weight loss with behavioral methods alone

Studies have shown that there is a bidirectional relationship between NAFLD and type 2 diabetes, and that NAFLD may precede and/or promote the development of type 2 diabetes [2, 3]

IBM is characterized by primary pathological hallmarks, including protein amyloid aggregates in muscle fibers, inflammation, and loss of skeletal muscle 114,251

Includes GLP-1-friendly options like protein shakes, bento box ideas, and high-protein snack pairings

Warning: Do not use if pregnant or breast feeding, elderly, under the age of 18 or if safety seal is broken

The ameliorative effects of Spirulina platensis against diethylnitrosamine induced hepatotoxicity in rats